Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status.
about
Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cellsBetulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.Inhibition of Ras for cancer treatment: the search continues.Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.Plant-derived triterpenoids and analogues as antitumor and anti-HIV agentsPreclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence.C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells.Emerging MEK inhibitors.Signaling pathways as therapeutic targets in biliary tract cancer.JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process.Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells
P2860
Q29248583-496E76FD-87A1-4DA3-B2C5-241288BF1553Q33755743-097ECAB5-1922-4790-A184-BA9CD66EB4F5Q34307356-F0ECCCDB-BAB2-40A6-82D3-707B90CCFE12Q35679353-287B4B41-F2DA-4C23-B697-40BE5D8191C4Q35944601-2758E8C3-7CC5-471A-A227-383D2AD854CBQ37024040-10325F61-94F4-4B82-B929-AAA50B49EF84Q37109225-A5F3EDC0-71F5-49B1-A85F-FB816C532E0EQ37173329-89EAF660-402D-4211-A4E5-B8B58015285BQ37421431-490BC060-A617-4AA3-81D5-E4FFC03E19F6Q37618297-5F6ECAD5-130F-481F-8A59-0E8530DD7376Q37645459-FB9A4590-69C1-4734-AF8F-905DEA880CE5Q37691441-852B4836-F1FC-42A8-A9D9-EF8AA1A724D3Q38747573-7151B96C-9D25-46E1-8279-84318BC3781EQ39384513-BA524DEB-1F16-4B3B-BD6D-93E0D707AC0AQ39394956-418D122F-EE6D-4B05-8FF0-46927565DCB4Q40813050-108E1B6F-7D04-4477-BA21-F89A815A8CABQ57840401-4A7F2083-ABA7-4932-93EC-62F559AD47D6
P2860
Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Signalling responses linked to ...... ma irrespective of p53 status.
@ast
Signalling responses linked to ...... ma irrespective of p53 status.
@en
type
label
Signalling responses linked to ...... ma irrespective of p53 status.
@ast
Signalling responses linked to ...... ma irrespective of p53 status.
@en
prefLabel
Signalling responses linked to ...... ma irrespective of p53 status.
@ast
Signalling responses linked to ...... ma irrespective of p53 status.
@en
P2860
P356
P1476
Signalling responses linked to ...... ma irrespective of p53 status.
@en
P2093
Manuel Rieber
Mary Strasberg Rieber
P2860
P304
P356
10.1002/IJC.21478
P577
2006-03-01T00:00:00Z